Back to Search
Start Over
Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity.
- Source :
-
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2018 Dec; Vol. 142 (6), pp. 1983-1987. Date of Electronic Publication: 2018 Aug 17. - Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 1097-6825
- Volume :
- 142
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- The Journal of allergy and clinical immunology
- Publication Type :
- Report
- Accession number :
- 30125661
- Full Text :
- https://doi.org/10.1016/j.jaci.2018.07.030